COMMUNIQUÉS West-GlobeNewswire

Ossur Hf :Transactions in relation to share buyback program

19/11/2018 - 17:01

Announcement no. 67/2018 19 November 2018 Transactions in relation to share buyback program On 9 October 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2018. The purpose of the share [...]

Replacement CT Tube Solutions from Richardson Healthcare at RSNA 2018

19/11/2018 - 17:00

Stop by Booth 7330 to see the ALTA750™ CT Tube LAFOX, Ill., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Richardson Healthcare , a Division of Richardson Electronics, Ltd. (NASDAQ: RELL), will be displaying the ALTA750 replacement [...]

UPDATE -- Cellworks to Present 10 Abstracts at 2018 American Society of Hematology Annual Meeting

19/11/2018 - 16:41

ASH Abstracts Reveal How AI-Driven Biosimulation Technology Predicts Drug Response in Individual Cancer Patients with High Accuracy SAN JOSE, Calif., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Cellworks Group, Inc., a leader in [...]

Cellworks to Present 10 Abstracts at 2019 American Society of Hematology Annual Meeting

19/11/2018 - 16:00

ASH Abstracts Reveal How AI-Driven Biosimulation Technology Predicts Drug Response in Individual Cancer Patients with High Accuracy SAN JOSE, Calif., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Cellworks Group, Inc., a leader in [...]

ESPERITE (ESP) announces publication of its Annual Report 2017 before 24 November 2018

19/11/2018 - 15:36

Amsterdam, The Netherlands - 19 November 2018 Esperite announces that the preparation of its Annual Report 2017 is now under final review by its auditors and should be published before 24 November 2018. About ESPERITE [...]

Galectin Therapeutics to Present at the 2nd Annual Anti-Fibrotic Drug Development Summit

19/11/2018 - 15:19

NORCROSS, Ga., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced that Dr. Harold H. Shlevin, the Company’s [...]

Corcept Therapeutics Announces First Patient Dosed in Phase 3 Trial of Relacorilant to Treat Patients with Cushing’s Syndrome

19/11/2018 - 15:05

MENLO PARK, Calif., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a company engaged in the discovery, development and commercialization of drugs to treat severe metabolic, oncologic [...]

Akers Biosciences Exploring Potential Business Combinations in Alternative Sectors Including Cannabis Industry

19/11/2018 - 15:01

THOROFARE, N.J., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, is pleased to provide an [...]

Who Will Become the LaCroix of CBD Beverages -- CFN Media

19/11/2018 - 15:00

SEATTLE, Nov. 19, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]

TOMI Environmental Solutions, Inc. Reports Record Third Quarter 2018 Financial Results

19/11/2018 - 15:00

BEVERLY HILLS, Calif., Nov. 19, 2018 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. (“TOMI”) (OTCQX:TOMZ), a global provider of infection prevention and decontamination products, services and research, including [...]

Lotus Cannabis LP - Launches Strategic Plan

19/11/2018 - 15:00

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Lotus Ventures Inc. (CSE – J) (“the Company”) held a strategy [...]

Immuron Appoints Gary S. Jacob, Ph.D., Experienced US Based Biotechnology Executive, as CEO

19/11/2018 - 15:00

MELBOURNE, Australia, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Immuron Limited, (IMC or the Company), (ASX: IMC; NASDAQ: IMRN), is pleased to announce the appointment of Gary S. Jacob as Chief Executive Officer. Dr Jacob is [...]

Rocket delivers cell samples to ISS to study effects of microgravity on muscles

19/11/2018 - 15:00

Muscle cells from Florida Hospital’s Translational Research Institute will be used to develop treatments for age-related muscle loss. ORLANDO, Fla., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Several Central Floridians are on a [...]

TRACON Pharmaceuticals Presents Data from Phase 2 Trial of TRC102 and Temodar® in Patients with Recurrent Glioblastoma at Society for Neuro-Oncology Annual Meeting

19/11/2018 - 14:35

SAN DIEGO, Nov. 19, 2018 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, [...]

Teladoc Health to Participate in Upcoming Investor Conference

19/11/2018 - 14:35

PURCHASE, NY, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Teladoc Health , Inc. (NYSE: TDOC), the global leader in virtual care, announced today that Jason Gorevic, chief executive officer, will participate in the following [...]

Anchiano Therapeutics Reports Third Quarter 2018 Financial and Operational Results

19/11/2018 - 14:30

CAMBRIDGE, Mass., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Anchiano Therapeutics (TASE: ANCN), a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat cancer, today [...]

Adverum Announces First Patient Dosed in OPTIC Phase 1 Trial of ADVM-022 Gene Therapy in Wet Age-Related Macular Degeneration

19/11/2018 - 14:30

ADVM-022 is the first intravitreally delivered gene therapy utilizing directed evolution AAV.7m8 vector for wet AMD OPTIC trial to evaluate single administration of ADVM-022 for wet AMD Interim trial update expected by [...]

Atara Biotherapeutics Announces Publication of Phase 1 Study Demonstrating Clinical Improvement in Progressive Multiple Sclerosis Patients Treated with ATA190, an Autologous Epstein-Barr Virus (EBV)-Specific T-Cell Immunotherapy

19/11/2018 - 14:30

Findings reported in an article online and to be published in the December 2018 issue of the JCI Insight SOUTH SAN FRANCISCO, Calif., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a [...]

AxoGen Advances its Platform for Nerve Repair at Annual Analyst and Investor Day

19/11/2018 - 14:23

Updates Value of the Market Opportunity in Existing Applications from $2.2 Billion to $2.7 Billion Announces Market Development and Clinical Initiatives for Expanded Application in the Surgical Treatment of Chronic [...]